Samtidig brug af sirolimus og calcineurinhæmmer øger muligvis risikoen for calcineurinhæmmer - induceret HUS/ TTP/ TMA.
The concomitant use of sirolimus with a calcineurin inhibitor may increase the risk of calcineurin inhibitor-induced HUS/ TTP/ TMA.